1 - 25 of
120
results
for author:"Nelson J."
in Literature Citations
| Mutations in PYCR1 cause cutis laxa with progeroid features. Reversade B., Escande-Beillard N., Dimopoulou A., Fischer B., Chng S.C., Li Y., Shboul M., Tham P.-Y., Kayserili H., Al-Gazali L. et al. |
| Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi. Koening C.L., Miller J.C., Nelson J.M., Ward D.M., Kushner J.P., Bockenstedt L.K., Weis J.J., Kaplan J., De Domenico I. Blood 114:1913-1918(2009) · Mapped (12) |
| P58(IPK): a novel "CIHD" member of the host innate defense response against pathogenic virus infection. Goodman A.G., Fornek J.L., Medigeshi G.R., Perrone L.A., Peng X., Dyer M.D., Proll S.C., Knoblaugh S.E., Carter V.S., Korth M.J. et al. PLoS Pathog. 5:e1000438-e1000438(2009) · Mapped (3) |
| The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. Hosseinipour M.C., van Oosterhout J.J., Weigel R., Phiri S., Kamwendo D., Parkin N., Fiscus S.A., Nelson J.A., Eron J.J., Kumwenda J. AIDS 23:1127-1134(2009) · UniProtKB (188) |
| Evolution of new disease specificity at a simple resistance locus in a crop-weed complex: reconstitution of the Lr21 gene in wheat. Huang L., Brooks S., Li W., Fellers J., Nelson J.C., Gill B. Genetics 182:595-602(2009) · UniProtKB (1) |
| The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype. Rueda B., Broen J., Simeon C., Hesselstrand R., Diaz B., Suarez H., Ortego-Centeno N., Riemekasten G., Fonollosa V., Vonk M.C. et al. Hum. Mol. Genet. 18:2071-2077(2009) · Mapped (8) |
| Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study. Schnabel R., Dupuis J., Larson M.G., Lunetta K.L., Robins S.J., Zhu Y., Rong J., Yin X., Stirnadel H.A., Nelson J.J. et al. Atherosclerosis 204:601-607(2009) · Mapped (4) |
| A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Rueda B., Simeon C., Hesselstrand R., Herrick A., Worthington J., Ortego-Centeno N., Riemekasten G., Fonollosa V., Vonk M.C., van den Hoogen F.H. et al. Ann. Rheum. Dis. 68:1618-1620(2009) · Mapped (7) |
| A single amino acid change in the yeast vacuolar metal transporters ZRC1 and COT1 alters their substrate specificity. Lin H., Kumanovics A., Nelson J.M., Warner D.E., Ward D.M., Kaplan J. J. Biol. Chem. 283:33865-33873(2008) · Mapped (5) |
| CSR1 induces cell death through inactivation of CPSF3. Zhu Z.H., Yu Y.P., Shi Y.K., Nelson J.B., Luo J.H. Oncogene 28:41-51(2009) · Mapped (1) |
| Non-inherited maternal human leukocyte antigen alleles in susceptibility to familial rheumatoid arthritis. Guthrie K.A., Tishkevich N.R., Nelson J.L. Ann. Rheum. Dis. 68:107-109(2009) · Mapped (458) |
| The hepcidin-binding site on ferroportin is evolutionarily conserved. De Domenico I., Nemeth E., Nelson J.M., Phillips J.D., Ajioka R.S., Kay M.S., Kushner J.P., Ganz T., Ward D.M., Kaplan J. Cell Metab. 8:146-156(2008) · Mapped (8) |
| Development and implementation of split-GFP-based bimolecular fluorescence complementation (BiFC) assays in yeast. Barnard E., McFerran N.V., Trudgett A., Nelson J., Timson D.J. Biochem. Soc. Trans. 36:479-482(2008) · Mapped (2) |
| Detection and localisation of protein-protein interactions in Saccharomyces cerevisiae using a split-GFP method. Barnard E., McFerran N.V., Trudgett A., Nelson J., Timson D.J. Fungal Genet. Biol. 45:597-604(2008) · Mapped (8) |
| The 67 kDa laminin receptor: structure, function and role in disease. Nelson J., McFerran N.V., Pivato G., Chambers E., Doherty C., Steele D., Timson D.J. Biosci. Rep. 28:33-48(2008) · Mapped (2) |
| Lp-PLA2 activity and mass are associated with increased incidence of ischemic stroke: a population-based cohort study from Malmo, Sweden. Persson M., Berglund G., Nelson J.J., Hedblad B. Atherosclerosis 200:191-198(2008) · Mapped (4) |
| Transcription of laminin gamma1 chain gene in rat mesangial cells: constitutive and inducible RNA polymerase II recruitment and chromatin states. Nelson J.D., Flanagin S., Kawata Y., Denisenko O., Bomsztyk K. Am. J. Physiol. Renal Physiol. 294:F525-33(2008) · Mapped (1) |
| PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib. Engelman J.A., Zejnullahu K., Gale C.M., Lifshits E., Gonzales A.J., Shimamura T., Zhao F., Vincent P.W., Naumov G.N., Bradner J.E. et al. Cancer Res. 67:11924-11932(2007) · Mapped (23) |
| Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Yu Y.P., Yu G., Tseng G., Cieply K., Nelson J., Defrances M., Zarnegar R., Michalopoulos G., Luo J.H. Cancer Res. 67:8043-8050(2007) · Mapped (25) |
| West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. Medigeshi G.R., Lancaster A.M., Hirsch A.J., Briese T., Lipkin W.I., Defilippis V., Fruh K., Mason P.W., Nikolich-Zugich J., Nelson J.A. J. Virol. 81:10849-10860(2007) · Mapped (2) |
| HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Nelson J.E., Bhattacharya R., Lindor K.D., Chalasani N., Raaka S., Heathcote E.J., Miskovsky E., Shaffer E., Rulyak S.J., Kowdley K.V. Hepatology 46:723-729(2007) · Mapped (20) |
| Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma. Ren B., Yu Y.P., Tseng G.C., Wu C., Chen K., Rao U.N., Nelson J., Michalopoulos G.K., Luo J.H. J. Natl. Cancer Inst. 99:868-880(2007) · Mapped (6) |
| Independent evolution of human immunodeficiency virus type 1 env V1/V2 and V4/V5 hypervariable regions during chronic infection. Harrington P.R., Nelson J.A., Kitrinos K.M., Swanstrom R. J. Virol. 81:5413-5417(2007) · UniProtKB (114) |
| An ent-kaurene that inhibits mitotic chromosome movement and binds the kinetochore protein ran-binding protein 2. Rundle N.T., Nelson J., Flory M.R., Joseph J., Th'ng J., Aebersold R., Dasso M., Andersen R.J., Roberge M. ACS Chem. Biol. 1:443-450(2006) · Mapped (4) |
| The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. O'Hara S.P., Small A.J., Nelson J.B., Badley A.D., Chen X.M., Gores G.J., Larusso N.F. Infect. Immun. 75:684-696(2007) · Mapped (4) |
